While current methods have transformed modern therapeutics, they remain constrained by poor oral bioavailability, stability challenges, cold-chain dependence, and limited patient acceptability associated with injectable administration, according to a review in AAPS PharmSciTech
Oja K, DNP
High Purity & Stability: Receptor-grade standard ensures consistency, stability, and repeatability across experimental trials
Wang L, Tan A, An X, Xia Y, Xie Y (2020) Quercetin Dihydrate inhibition of cardiac fibrosis induced by angiotensin II in vivo and in vitro
Xeomin contains highly diluted botulinum toxin type A, which is a widely used for both medical and cosmetic treatment and is the same protein as Botox and Dysport